NewsBenzingaNovartis: BPA ajustado del tercer trimestre de 2,46 dólares supera la estimación de 2,27 dólares; ventas de 14.522 millones de dólares no alcanzan la estimación de 14.582 millones de dólares Novartis: BPA ajustado del tercer trimestre de 2,46 dólares supera la estimación de 2,27 dólares; ventas de 14.522 millones de dólares no alcanzan la estimación de 14.582 millones de dólares Benzinga 2026.10.27 07:01 (GMT+0) Open on Benzinga Other news Top Wall Street Forecasters Revamp PayPal Expectations Ahead Of Q3 Earnings Pharming Affirms FY2026 Sales Guidance of $380.000M-$390.000M vs $383.333M Est Elizabeth Warren Sees 2008-Style Warning Signs in AI Boom — ‘Trump’s Regulators Are Choosing to Look the Other Way’ Binance Margin to Remove RE/USD1, 币安人生/U and Other Trading Pairs on October 30 ‘Where Are The Cybercabs?’ Tesla Investor Ross Gerber Takes Aim at Elon Musk as Amazon’s Zoox Eyes Expansion With Santa Monica Deal for 150 Robotaxis Reported Earlier, Five Star Q3 EPS $0.92 Beats $0.85 Estimate, Sales $52.620M Beat $50.069M Estimate
Elizabeth Warren Sees 2008-Style Warning Signs in AI Boom — ‘Trump’s Regulators Are Choosing to Look the Other Way’
‘Where Are The Cybercabs?’ Tesla Investor Ross Gerber Takes Aim at Elon Musk as Amazon’s Zoox Eyes Expansion With Santa Monica Deal for 150 Robotaxis
